Top Story

Infective endocarditis after TAVR associated with poor outcomes

May 28, 2015

Among patients undergoing transcatheter aortic valve replacement, those who developed infective endocarditis had a high rate of mortality and other poor outcomes, according to recent findings.

The researchers studied the incidence, predictors, clinical characteristics, management and outcomes in 53 patients who experienced infective endocarditis after TAVR from a cohort of 7,944 patients followed for a mean of 1.1 years. The incidence rate of infective endocarditis was 0.67% overall and 0.5% within the first year after TAVR. The mean duration between TAVR and incidence was 6 months (interquartile range, 1-14 months).

Harvoni added benefit for patients with HCV/HIV coinfection

May 28, 2015
In a manufacturer dossier assessment conducted by the Institute for Quality and Efficiency in Health Care in Germany, Harvoni was deemed to have an added benefit for…

CMS proposes updated Medicaid, CHIP-managed care regulations

May 28, 2015
CMS recently proposed a rule to update managed care regulations for Medicaid and the Children’s Health Insurance Program, according to a press release.The…
Keiji Fukuda

World Health Assembly backs plan to reduce antimicrobial resistance

May 28, 2015
The World Health Assembly, which recently concluded its annual meeting in Geneva, approved a resolution this week to address antimicrobial resistance worldwide…
In the Journals

Health officials' quick response saves lives in 2012 meningitis outbreak

May 27, 2015
The 2012-2013 fungal meningitis outbreak that sickened more than 750 people and contributed to 64 deaths may have had an even greater impact if not for the swift…
More News Headlines »
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »
Meeting News Coverage Video
VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

April 25, 2015
VIENNA — Howard Monsour Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of…
More »

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
morganatic-roan morganatic-roan